| # |
PMID |
Sentence |
| 1 |
11141501
|
Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
|
| 2 |
11141501
|
Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments.
|
| 3 |
11141501
|
Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis.
|
| 4 |
11141501
|
We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I.
|
| 5 |
11141501
|
A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I.
|
| 6 |
11141501
|
Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting.
|
| 7 |
11141501
|
Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation.
|
| 8 |
11141501
|
HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels.
|
| 9 |
11141501
|
The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway.
|
| 10 |
11141501
|
Apoptosis was prevented by pretreatment with HGF but not IGF-I.
|
| 11 |
11141501
|
Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
|
| 12 |
11141501
|
Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments.
|
| 13 |
11141501
|
Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis.
|
| 14 |
11141501
|
We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I.
|
| 15 |
11141501
|
A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I.
|
| 16 |
11141501
|
Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting.
|
| 17 |
11141501
|
Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation.
|
| 18 |
11141501
|
HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels.
|
| 19 |
11141501
|
The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway.
|
| 20 |
11141501
|
Apoptosis was prevented by pretreatment with HGF but not IGF-I.
|
| 21 |
11141501
|
Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.
|
| 22 |
11141501
|
Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments.
|
| 23 |
11141501
|
Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis.
|
| 24 |
11141501
|
We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I.
|
| 25 |
11141501
|
A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I.
|
| 26 |
11141501
|
Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting.
|
| 27 |
11141501
|
Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation.
|
| 28 |
11141501
|
HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels.
|
| 29 |
11141501
|
The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway.
|
| 30 |
11141501
|
Apoptosis was prevented by pretreatment with HGF but not IGF-I.
|